Close Menu
May 19, 2020
Sponsored by
10x Genomics

Using Single-Cell Multiomics to Reveal New Insights into Uveal Melanoma Evolution and Therapeutic Resistance


Professor and Associate Director for Basic Science at Sylvester Comprehensive Cancer Center of the University of Miami

Harbour Ocular Oncology Laboratory, MSTP MD/PhD Program, University of Miami Miller School of Medicine


Uveal melanoma (UM) is a highly metastatic cancer that, in contrast to cutaneous melanoma, is largely unresponsive to checkpoint immunotherapy. Despite a well characterized genomic landscape and prognostically distinct molecular subtypes, a complete understanding of UM progression, metastasis and therapeutic resistance remains elusive.

Join Dr. J. William Harbour, Professor and Associate Director for Basic Science at Sylvester Comprehensive Cancer Center of the University of Miami, for a webinar to learn more about his recently published research studying the evolution of UM tumors and their microenvironments.  Using single-cell approaches from 10x Genomics for gene expression, genomic copy number variation (CNV), and T- and B-cell receptor typing, Dr. Harbour and team comprehensively characterized eight primary tumors and three metastatic tumors revealing new insights into UM biology and identifying a new putative checkpoint inhibitor target, LAG3.

During this webinar you will learn about how Dr. Harbour and team:

  • Explored the tumor microenvironment by analyzing gene expression profiles from 59,915 single cells from eight primary and three metastatic tumors to identify key gene expression differences across the tumor classes
  • Used transcriptional trajectory analysis to elucidate the transcriptional states of cells, confirming defined states for class 1 and 2 primary tumors and suggesting phenotypic plasticity within tumors
  • Combined single-cell T-cell receptor typing and gene expression data to reveal clonally expanded exhausted T-cell populations and identify LAG3 as a putative checkpoint inhibitor target
Sponsored by

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.

Sponsored by

In this webinar, Dr. Charlie Johnson, founder of the Texas A&M AgriLife Genomics and Bioinformatics Service, will share how his team is utilizing Illumina’s DRAGEN informatics platform in its high-throughput agrigenomics research program. 

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.